Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Chatelut

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinomaE Chatelut, C Chevreau, E Blancy, et al.
Cancer Chemotherapy and Pharmacology|December 18, 2007
Pharmacokinetics of heated intraperitoneal oxaliplatinG Ferron, S Dattez, L Gladieff, et al.
Bulletin Du Cancer|September 19, 2009
[Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel]L Simon, M-C Halilou, L Gladieff, et al.
Cancer Chemotherapy and Pharmacology|November 25, 2006
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effectF Puisset, E Chatelut, A Sparreboom, et al.
Bulletin Du Cancer|August 1, 1995
[Relations between hematological toxicity and total and free plasma levels of etoposide in daily oral administration]M Lavit, C Chevreau, E Chatelut, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
A limited-sampling method for evaluation of the area under the curve of ultrafilterable carboplatin in childrenF Doz, S Urien, E Chatelut, et al.
Journal of Pharmaceutical Sciences|August 1, 1991
Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in childrenE Chatelut, H Roche, Y Plusquellec, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignanciesC Mita, E Chatelut, M Bekradda, et al.
British Journal of Clinical Pharmacology|May 8, 1999
A pharmacokinetic model for alpha interferon administered subcutaneouslyE Chatelut, L Rostaing, N Grégoire, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusionC Muller, E Chatelut, V Gualano, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinomaE Chatelut, C Chevreau, E Blancy, et al.
Cancer Chemotherapy and Pharmacology|December 18, 2007
Pharmacokinetics of heated intraperitoneal oxaliplatinG Ferron, S Dattez, L Gladieff, et al.
Bulletin Du Cancer|September 19, 2009
[Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel]L Simon, M-C Halilou, L Gladieff, et al.
Cancer Chemotherapy and Pharmacology|November 25, 2006
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effectF Puisset, E Chatelut, A Sparreboom, et al.
Bulletin Du Cancer|August 1, 1995
[Relations between hematological toxicity and total and free plasma levels of etoposide in daily oral administration]M Lavit, C Chevreau, E Chatelut, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
A limited-sampling method for evaluation of the area under the curve of ultrafilterable carboplatin in childrenF Doz, S Urien, E Chatelut, et al.
Journal of Pharmaceutical Sciences|August 1, 1991
Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in childrenE Chatelut, H Roche, Y Plusquellec, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignanciesC Mita, E Chatelut, M Bekradda, et al.
British Journal of Clinical Pharmacology|May 8, 1999
A pharmacokinetic model for alpha interferon administered subcutaneouslyE Chatelut, L Rostaing, N Grégoire, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusionC Muller, E Chatelut, V Gualano, et al.
Pageof 8